Finance

Beta
Lists
PHE:FRA
Cipher Pharmaceuticals Inc
€9.90
-3.88%
(-0.40) 1D
Jun 3, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PHE...
Open
€9.90
High
€10.20
Low
€9.90
Mkt. cap
419.46M
Avg. vol.
19.00
Volume
0.00
52-wk high
€12.20
52-wk low
€7.00
No. of employees
43
Open
€9.90
High
€10.20
Low
€9.90
Mkt. cap
419.46M
Avg. vol.
19.00
Volume
0.00
52-wk high
€12.20
52-wk low
€7.00
No. of employees
43
News stories
From sources across the web
About Cipher Pharmaceuticals Inc
CEO-
Employees43
Founded2000
HeadquartersMississauga, Ontario, Canada
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
13.38M
12.83M
12.22M
12.50M
Cost of goods sold
2.50M
2.35M
2.30M
2.21M
Cost of revenue
2.50M
2.35M
2.30M
2.21M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.08M
3.71M
3.68M
2.90M
Operating expense
5.89M
5.51M
5.49M
4.70M
Total operating expenses
8.39M
7.86M
7.79M
6.91M
Operating income
4.99M
4.97M
4.43M
5.60M
Other non operating income
-
-
-
-
EBT including unusual items
6.40M
4.26M
4.61M
4.95M
EBT excluding unusual items
6.40M
4.13M
4.84M
4.89M
Income tax expense
512.00K
-1.24M
-8.70M
-1.21M
Effective tax rate
7.99%
-29.19%
-188.55%
-24.53%
Other operating expenses
-
-
-
-
Net income
5.89M
5.50M
13.31M
6.16M
Net profit margin
44.04%
42.87%
108.95%
49.28%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-345.00K
-241.00K
-109.00K
-51.00K
Net interest expenses
-345.00K
-241.00K
-109.00K
-51.00K
Depreciation and amortization charges
1.81M
1.80M
1.81M
1.81M
EBITDA
6.80M
6.77M
5.95M
7.40M
Gain or loss from assets sale
-
-
-130.00K
-57.00K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more